nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE8B—forelimb—peripheral nervous system neoplasm	0.0569	0.266	CbGeAlD
Flavoxate—PDE8B—ganglion—peripheral nervous system neoplasm	0.0308	0.144	CbGeAlD
Flavoxate—PDE4C—ganglion—peripheral nervous system neoplasm	0.0285	0.133	CbGeAlD
Flavoxate—PDE4C—tongue—peripheral nervous system neoplasm	0.0282	0.132	CbGeAlD
Flavoxate—PDE8A—trigeminal ganglion—peripheral nervous system neoplasm	0.0136	0.0635	CbGeAlD
Flavoxate—PDE4C—brainstem—peripheral nervous system neoplasm	0.0124	0.0579	CbGeAlD
Flavoxate—PDE8B—cerebellum—peripheral nervous system neoplasm	0.00659	0.0308	CbGeAlD
Flavoxate—PDE4B—trigeminal ganglion—peripheral nervous system neoplasm	0.0065	0.0304	CbGeAlD
Flavoxate—PDE4B—parotid gland—peripheral nervous system neoplasm	0.00613	0.0286	CbGeAlD
Flavoxate—PDE8A—cerebellum—peripheral nervous system neoplasm	0.00593	0.0277	CbGeAlD
Flavoxate—CHRM1—parotid gland—peripheral nervous system neoplasm	0.00554	0.0259	CbGeAlD
Flavoxate—PDE4D—cerebellum—peripheral nervous system neoplasm	0.00538	0.0251	CbGeAlD
Flavoxate—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00501	0.0202	CcSEcCtD
Flavoxate—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00501	0.0202	CcSEcCtD
Flavoxate—PDE4A—cerebellum—peripheral nervous system neoplasm	0.00476	0.0222	CbGeAlD
Flavoxate—Tension—Tretinoin—peripheral nervous system neoplasm	0.00385	0.0155	CcSEcCtD
Flavoxate—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00385	0.0155	CcSEcCtD
Flavoxate—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00381	0.0153	CcSEcCtD
Flavoxate—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00381	0.0153	CcSEcCtD
Flavoxate—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.0038	0.0153	CcSEcCtD
Flavoxate—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00369	0.0149	CcSEcCtD
Flavoxate—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00369	0.0149	CcSEcCtD
Flavoxate—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00354	0.0142	CcSEcCtD
Flavoxate—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00346	0.0139	CcSEcCtD
Flavoxate—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00346	0.0139	CcSEcCtD
Flavoxate—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00346	0.0139	CcSEcCtD
Flavoxate—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00326	0.0131	CcSEcCtD
Flavoxate—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00326	0.0131	CcSEcCtD
Flavoxate—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00322	0.013	CcSEcCtD
Flavoxate—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00322	0.013	CcSEcCtD
Flavoxate—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00313	0.0126	CcSEcCtD
Flavoxate—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00312	0.0126	CcSEcCtD
Flavoxate—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00312	0.0126	CcSEcCtD
Flavoxate—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00311	0.0125	CcSEcCtD
Flavoxate—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00311	0.0125	CcSEcCtD
Flavoxate—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00308	0.0124	CcSEcCtD
Flavoxate—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00307	0.0123	CcSEcCtD
Flavoxate—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00291	0.0117	CcSEcCtD
Flavoxate—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.0116	CcSEcCtD
Flavoxate—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00287	0.0115	CcSEcCtD
Flavoxate—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00284	0.0114	CcSEcCtD
Flavoxate—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00284	0.0114	CcSEcCtD
Flavoxate—PDE4B—cerebellum—peripheral nervous system neoplasm	0.00284	0.0133	CbGeAlD
Flavoxate—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.0028	0.0113	CcSEcCtD
Flavoxate—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00266	0.0107	CcSEcCtD
Flavoxate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00264	0.0106	CcSEcCtD
Flavoxate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00264	0.0106	CcSEcCtD
Flavoxate—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00262	0.0106	CcSEcCtD
Flavoxate—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00257	0.0103	CcSEcCtD
Flavoxate—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00256	0.0103	CcSEcCtD
Flavoxate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00256	0.0103	CcSEcCtD
Flavoxate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00254	0.0102	CcSEcCtD
Flavoxate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00254	0.0102	CcSEcCtD
Flavoxate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00251	0.0101	CcSEcCtD
Flavoxate—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00247	0.00995	CcSEcCtD
Flavoxate—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00984	CcSEcCtD
Flavoxate—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00238	0.0096	CcSEcCtD
Flavoxate—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00237	0.00952	CcSEcCtD
Flavoxate—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00948	CcSEcCtD
Flavoxate—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00226	0.00912	CcSEcCtD
Flavoxate—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00867	CcSEcCtD
Flavoxate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00215	0.00867	CcSEcCtD
Flavoxate—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00208	0.00838	CcSEcCtD
Flavoxate—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00208	0.00835	CcSEcCtD
Flavoxate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00205	0.00825	CcSEcCtD
Flavoxate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00818	CcSEcCtD
Flavoxate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00818	CcSEcCtD
Flavoxate—Headache—Topotecan—peripheral nervous system neoplasm	0.00202	0.00813	CcSEcCtD
Flavoxate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00202	0.00811	CcSEcCtD
Flavoxate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00201	0.00808	CcSEcCtD
Flavoxate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00201	0.00807	CcSEcCtD
Flavoxate—Headache—Tretinoin—peripheral nervous system neoplasm	0.002	0.00806	CcSEcCtD
Flavoxate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.002	0.00806	CcSEcCtD
Flavoxate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.002	0.00804	CcSEcCtD
Flavoxate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.00775	CcSEcCtD
Flavoxate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00191	0.00771	CcSEcCtD
Flavoxate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00191	0.00768	CcSEcCtD
Flavoxate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0019	0.00765	CcSEcCtD
Flavoxate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0019	0.00765	CcSEcCtD
Flavoxate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00188	0.00755	CcSEcCtD
Flavoxate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00185	0.00743	CcSEcCtD
Flavoxate—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00743	CcSEcCtD
Flavoxate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00184	0.0074	CcSEcCtD
Flavoxate—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00688	CcSEcCtD
Flavoxate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.0017	0.00685	CcSEcCtD
Flavoxate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00168	0.00677	CcSEcCtD
Flavoxate—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00669	CcSEcCtD
Flavoxate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00166	0.00669	CcSEcCtD
Flavoxate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00156	0.00628	CcSEcCtD
Flavoxate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00155	0.00625	CcSEcCtD
Flavoxate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.0062	CcSEcCtD
Flavoxate—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00154	0.00619	CcSEcCtD
Flavoxate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00611	CcSEcCtD
Flavoxate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.0015	0.00605	CcSEcCtD
Flavoxate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00148	0.00598	CcSEcCtD
Flavoxate—Headache—Vincristine—peripheral nervous system neoplasm	0.00146	0.00589	CcSEcCtD
Flavoxate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00579	CcSEcCtD
Flavoxate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00139	0.00558	CcSEcCtD
Flavoxate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00529	CcSEcCtD
Flavoxate—Tension—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00513	CcSEcCtD
Flavoxate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00508	CcSEcCtD
Flavoxate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00494	CcSEcCtD
Flavoxate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00493	CcSEcCtD
Flavoxate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0012	0.00484	CcSEcCtD
Flavoxate—Headache—Etoposide—peripheral nervous system neoplasm	0.00119	0.00477	CcSEcCtD
Flavoxate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00475	CcSEcCtD
Flavoxate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.0047	CcSEcCtD
Flavoxate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00117	0.0047	CcSEcCtD
Flavoxate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00468	CcSEcCtD
Flavoxate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00462	CcSEcCtD
Flavoxate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00456	CcSEcCtD
Flavoxate—Nausea—Etoposide—peripheral nervous system neoplasm	0.00112	0.00452	CcSEcCtD
Flavoxate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00436	CcSEcCtD
Flavoxate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00435	CcSEcCtD
Flavoxate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00433	CcSEcCtD
Flavoxate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00107	0.0043	CcSEcCtD
Flavoxate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00428	CcSEcCtD
Flavoxate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00417	CcSEcCtD
Flavoxate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00415	CcSEcCtD
Flavoxate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00403	CcSEcCtD
Flavoxate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000989	0.00398	CcSEcCtD
Flavoxate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000958	0.00385	CcSEcCtD
Flavoxate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000953	0.00384	CcSEcCtD
Flavoxate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000943	0.00379	CcSEcCtD
Flavoxate—CHRM1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000889	0.00165	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000883	0.00164	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000883	0.00164	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000879	0.00164	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000875	0.00163	CbGpPWpGaD
Flavoxate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000874	0.00352	CcSEcCtD
Flavoxate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000872	0.00351	CcSEcCtD
Flavoxate—PDE4C—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000871	0.00162	CbGpPWpGaD
Flavoxate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000842	0.00339	CcSEcCtD
Flavoxate—PDE4B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000824	0.00153	CbGpPWpGaD
Flavoxate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000809	0.00325	CcSEcCtD
Flavoxate—CHRM1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000791	0.00147	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000791	0.00147	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000787	0.00146	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000786	0.00146	CbGpPWpGaD
Flavoxate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.00314	CcSEcCtD
Flavoxate—PDE8A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000777	0.00145	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000777	0.00145	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000761	0.00142	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000758	0.00141	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000756	0.00141	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000756	0.00141	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000753	0.0014	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000732	0.00136	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000723	0.00134	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000722	0.00134	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00072	0.00134	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00072	0.00134	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000696	0.0013	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000693	0.00129	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000691	0.00129	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000688	0.00128	CbGpPWpGaD
Flavoxate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000674	0.00271	CcSEcCtD
Flavoxate—PDE7B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000674	0.00125	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000668	0.00124	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000665	0.00124	CbGpPWpGaD
Flavoxate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000664	0.00267	CcSEcCtD
Flavoxate—PDE4D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000662	0.00123	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000661	0.00123	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000661	0.00123	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000644	0.0012	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000642	0.00119	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000635	0.00118	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000632	0.00118	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00063	0.00117	CbGpPWpGaD
Flavoxate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00063	0.00254	CcSEcCtD
Flavoxate—PDE7A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000626	0.00116	CbGpPWpGaD
Flavoxate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.00251	CcSEcCtD
Flavoxate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000615	0.00247	CcSEcCtD
Flavoxate—PDE4C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000604	0.00112	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000601	0.00112	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000599	0.00111	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000597	0.00111	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000589	0.0011	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000583	0.00109	CbGpPWpGaD
Flavoxate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.00235	CcSEcCtD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000582	0.00108	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000579	0.00108	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000575	0.00107	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000572	0.00106	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00057	0.00106	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000557	0.00104	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000553	0.00103	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000551	0.00103	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00055	0.00102	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000548	0.00102	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00053	0.000985	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000528	0.000982	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000526	0.000979	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000526	0.000978	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00051	0.000949	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000506	0.000942	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000501	0.000931	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.0005	0.00093	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000487	0.000906	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000485	0.000903	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000479	0.000891	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000478	0.000889	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000477	0.000888	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000467	0.00087	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000467	0.00087	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000463	0.000862	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000459	0.000854	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000459	0.000854	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000443	0.000825	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000438	0.000814	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000437	0.000813	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000423	0.000786	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00042	0.000781	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000417	0.000776	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000417	0.000775	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000415	0.000773	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000409	0.000761	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000408	0.000759	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000395	0.000735	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000389	0.000724	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000388	0.000721	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000387	0.000721	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	0.000385	0.000717	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000384	0.000714	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000383	0.000712	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000381	0.000708	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	0.00038	0.000707	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000379	0.000705	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000366	0.00068	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000365	0.00068	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000363	0.000675	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000363	0.000675	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000357	0.000664	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000355	0.000661	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000354	0.000659	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00035	0.00065	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000348	0.000647	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000342	0.000636	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000342	0.000636	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000339	0.00063	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000338	0.000629	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000333	0.000619	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000333	0.000619	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000329	0.000613	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000329	0.000613	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000324	0.000602	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000322	0.0006	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000322	0.000599	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000313	0.000582	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000311	0.000578	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000305	0.000567	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000302	0.000562	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000302	0.000562	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000301	0.000559	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000299	0.000556	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000298	0.000555	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000296	0.000551	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000296	0.00055	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000295	0.000549	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000294	0.000546	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000287	0.000534	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000287	0.000533	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000283	0.000527	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000283	0.000527	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000276	0.000514	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000276	0.000514	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000276	0.000513	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000274	0.000509	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000273	0.000508	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000269	0.000501	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000257	0.000478	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000257	0.000478	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000252	0.00047	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000251	0.000466	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.00025	0.000465	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000248	0.000461	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000247	0.00046	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000246	0.000458	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000232	0.000431	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000229	0.000426	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000229	0.000426	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000227	0.000423	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000227	0.000422	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000225	0.000418	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000224	0.000416	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00022	0.000409	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000219	0.000407	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000216	0.000402	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000216	0.000402	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000213	0.000396	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000211	0.000393	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000211	0.000393	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.00021	0.000391	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000209	0.000389	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000209	0.000389	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000206	0.000384	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000205	0.000382	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000202	0.000376	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000202	0.000376	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000199	0.00037	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000196	0.000365	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000196	0.000365	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000194	0.00036	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00019	0.000354	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000188	0.00035	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000185	0.000344	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.00018	0.000335	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00018	0.000334	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000178	0.000332	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000178	0.000332	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000178	0.000331	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000175	0.000326	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000171	0.000317	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000167	0.000311	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000163	0.000303	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000162	0.000302	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000161	0.000299	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000159	0.000296	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000157	0.000292	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000156	0.000291	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000155	0.000288	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000155	0.000288	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000153	0.000285	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00015	0.00028	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000149	0.000277	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000149	0.000277	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000148	0.000275	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000147	0.000274	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000142	0.000264	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000142	0.000263	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000139	0.000258	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000138	0.000257	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000138	0.000256	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000136	0.000254	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000136	0.000254	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000135	0.000251	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000134	0.00025	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000133	0.000247	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00013	0.000241	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000128	0.000238	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000126	0.000235	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000125	0.000233	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000124	0.00023	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000121	0.000225	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000118	0.000219	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000116	0.000216	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000115	0.000214	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000114	0.000213	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000114	0.000212	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000109	0.000203	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000106	0.000198	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.93e-05	0.000185	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.63e-05	0.000179	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.5e-05	0.000177	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.45e-05	0.000176	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.04e-05	0.000168	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.75e-05	0.000163	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.39e-05	0.000156	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.36e-05	0.000156	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.31e-05	0.000155	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.21e-05	0.000153	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.17e-05	0.000152	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.06e-05	0.00015	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.98e-05	0.000148	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.38e-05	0.000137	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.45e-05	0.00012	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.37e-05	0.000119	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.08e-05	0.000113	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6e-05	0.000112	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.91e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.86e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.84e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.78e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.37e-05	9.99e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.3e-05	9.86e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.91e-05	9.13e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.85e-05	9.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.57e-05	8.51e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.51e-05	8.4e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.76e-05	6.99e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.71e-05	6.9e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.59e-05	6.68e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.55e-05	6.6e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.17e-05	5.9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.13e-05	5.82e-05	CbGpPWpGaD
